Adcetris (brentuximab vedotin)

pCPA File Number: 21371
Negotiation Status:
Active Negotiation
Indication(s):
Primary Cutaneous Anaplastic Large Cell Lymphoma (or CD30- Expressing Mycosis Fungoides)
Sponsor/Manufacturer:
Seattle Genetics Inc.
CADTH Project Number:
pCODR 10213
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable